Velia is an emerging biotech harnessing the broad therapeutic potential of a newly identified, yet abundant class of human proteins. Transformational work from Velia founders revealed that many of those previously overlooked proteins regulate biological functions vital to human health. Velia will discover and develop therapeutics targeting these novel regulators.
| Website | https://www.veliatx.com/ |
| Employees | 54 (2 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Emerging Biotech, Biotechnology, Biotechnology Research, Therapeutic Proteins, Human Proteins, Innovative Medicines, Protein Therapeutics, Biopharmaceutical, Drug Discovery, Biotech Research, Pharmaceutical Research, Life Sciences, Molecular Biology, Biologics, Protein Engineering, Therapeutic Development, Clinical Development, Drug Development, Bioprocessing, Pharmaceutical |
| Competitors | Siemens Healthineers, Roche, Medtronic, Thermo Fisher Scientific, Abbott, Quest Diagnostics, Labcorp, FiscalNote, Grupo Omnilife-Chivas, iRhythm Technologies International +42 more (view full list) |
Looking for a particular Velia employee's phone or email?
Michael York is the Chief Business Officer of Velia.
2 people are employed at Velia.
Velia is based in San Diego, California.